Sign in
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Monday, December 23, 2024
Sign in / Join
Facebook
Instagram
Twitter
Vimeo
Youtube
Pharma Deals
Update
Oncology
Search
Home
Pharma Deals
Pharma Deals
Captures information related to pharma deals
Collaboration agreement
Kissei Pharmaceuticals Enters into a Drug discovery research collaboration agreement with Reborna Biosciences.
pharmaquotient.com
-
9 September 2024
Collaboration agreement
Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
Licensing Agreement
Kissei Pharmaceuticals Enter into a Licensing Agreement with Rigel Pharmaceuticals for Rezlidhia”olutasidenib”, an Acute Myeloid Leukemia Drug
Merger & Acquisition
Collegium Pharmaceutical to Acquire Ironshore Therapeutics, Expanding into Neurology
Licensing Agreement
Kissei Pharmaceuticals enters into Licensing Agreement for GnRH Antagonist Linzagolix with JW Pharmaceutical Corporation in Korea
Merger & Acquisition
AbbVie Acquires Landos Biopharma for NX-13
pharmaquotient.com
-
23 May 2024
0
Pharma Deals
AbbVie and Gilgamesh Pharmaceuticals Collaborates to Develop Therapies for Psychiatric Disorders
pharmaquotient.com
-
13 May 2024
0
Merger & Acquisition
Merck Acquired Harpoon Therapeutics, Inc.
pharmaquotient.com
-
11 March 2024
0
Merger & Acquisition
Bristol Mayers Squibb Agrees to Acquire Mirati Therapeutics to Diversify its Oncology Portfolio for up to $5.8 B
pharmaquotient.com
-
8 October 2023
0
Merger & Acquisition
Novartis Divests front of eye Ophthalmic Assets to Bausch+Lomb
pharmaquotient.com
-
29 September 2023
0
Collaboration agreement
Otsuka and ShapeTX collaborates to develop novel AAV gene therapies for ocular diseases for up to $1.5B
pharmaquotient.com
-
8 September 2023
0
Merger & Acquisition
Blackstone, Torrent Pharma in race to acquire Cipla promoter stake
pharmaquotient.com
-
1 September 2023
0
Collaboration agreement
Gilead-Tentarix Collaborates to Develop Cancer and Inflammation Therapy for $66M
pharmaquotient.com
-
15 August 2023
0
Merger & Acquisition
Lilly Acquired Sigilon Therapeutics
pharmaquotient.com
-
14 August 2023
0
Oncology
Astellas invested $50 M in Poseida’s CAR-T Cell Therapy for Cancer
pharmaquotient.com
-
8 August 2023
0
Merger & Acquisition
Biogen to buy Reata Pharmaceuticals for up to $7.3 B
pharmaquotient.com
-
28 July 2023
0
Partnership agreement
Teva & Alvotech Provide Update on Strategic Biosimilars Partnership
pharmaquotient.com
-
24 July 2023
0
1
2
Page 1 of 2
Most Read
Neuralink’s Blindsight: A Breakthrough in Vision Restoration
20 September 2024
Theratechnologies Indicated Potential Supply Disruption for EGRIFTA SV® in Early 2025
17 September 2024
Kissei Pharmaceuticals Enters into a Drug discovery research collaboration agreement with Reborna Biosciences.
9 September 2024
Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
7 September 2024